Vulvar cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with primary vulvar carcinoma confirmed by histology, including squamous cell carcinoma of vulva, malignant melanoma of vulva, basal cell carcinoma of vulva, large adenocarcinoma of vestibule of vulva, etc; 2. FIGO stage IB / II / IIIA / IIIB; 3. Patients who underwent radical vulvectomy plus unilateral or bilateral inguinal lymphadenectomy; 4. Platelet >100 * 10^9/L; bilirubin not more than 1.5 times of normal value; alkaline phosphatase not more than 3 times of normal value; ast not more than 3 times of normal value; creatinine not more than 2.0 mg/dl; 5. Patients without contraindications; 6. Patients who voluntarily sign informed consent and are willing to be followed up.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiopulmonary disease or severe mental disorder; 2. Patients with severe coagulation dysfunction; 3. Patients with previous history of inguinal surgery; 4. Patients with ASA score > 3; 5. For other reasons, the researcher thinks it is not suitable to participate in the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| disease free survival rate;overall survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| rate of wound-related complications;operative time;bleeding volume;Number of lymph nodes excised;length postoperative hospital stay;cost; | — |
Countries
China
Contacts
Zhujiang Hospital of Southern Medical University